Recurrence risk evaluation in stage IB/IIA gastric cancer with TP53 codon 72 polymorphisms
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz239.064
Abstract: Abstract Background Post-operative adjuvant chemotherapy is not indicated for stage IB/IIA gastric cancer. However, approximately 10-30% of these patients experience recurrence and metastasis. In this study, we investigated the risk of recurrence after treatment of… read more here.
Keywords: gastric cancer; stage iia; tp53 codon; iia gastric ... See more keywords